Skip to main content
SpringerLink
Log in

Molecular modeling and synthesis of ZINC02765569 derivatives as protein tyrosine phosphatase 1B inhibitors: lead optimization study

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

This article describes design, synthesis, and molecular modeling studies of the ZINC02765569 derivatives as potent protein tyrosine phosphatase 1B (PTP1B) inhibitors, which was previously reported as a vHTS hit (ZINC02765569) by our laboratory. Ten compounds were synthesized and characterized by IR, MASS, and NMR followed by in vitro screening for PTP1B inhibition and glucose uptake in skeletal muscle L6 myotubes. The most potent compound 3j shows 66.4 % in vitro PTP1B inhibition and 39.6 % increase in glucose uptake. Glide was used to study the nature of interactions governing binding of designed molecules with active site of the PTP1B enzyme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ahmad F, Li PM, Meyerovitch J, Goldstein BJ (1995) Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 270:20503–22050

    Article  PubMed  CAS  Google Scholar 

  • Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ (1997a) Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100:449–458

    Article  PubMed  CAS  Google Scholar 

  • Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ (1997b) Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein–tyrosine phosphatases in adipose tissue. Metab Clin Exp 46:1140–1145

    Article  PubMed  CAS  Google Scholar 

  • Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, Kusari J (1997) Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine phosphorylated in the presence of insulin. J Biol Chem 272:1639–1645

    Article  PubMed  CAS  Google Scholar 

  • Blaskovich MA, Kim HO (2002) Recent discovery and development of protein tyrosine phosphatase inhibitors. Expert Opin Ther Pat 12:871–905

    Article  CAS  Google Scholar 

  • Bleasdale JE, Ogg D, Palazuk BJ et al (2001) Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. Biochemistry 40:5642–5654

    Article  PubMed  CAS  Google Scholar 

  • Blume JP, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365

    Article  Google Scholar 

  • Boutselis IG, Yu X, Zhang ZY, Borch RF (2007) Synthesis and cell based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. J Med Chem 50:856–864

    Article  PubMed  CAS  Google Scholar 

  • Burke TR, Ye B, Yan X, Wang S, Jia Z, Chen L, Zhang ZY, Barford D (1996a) Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design. Biochemistry 35:15989–15996

    Article  PubMed  CAS  Google Scholar 

  • Burke TR Jr., Ye B, Akamatsu M, Ford H Jr., Yan X, Kole HK, Wolf G, Shoelson SE, Roller PP (1996b) 40-o-[2-(2-fluoromalonyl)]-l-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides. J Med Chem 39:1021–1027

    Article  PubMed  CAS  Google Scholar 

  • Chen YT, Seto CT (2002) Divalent and trivalent alpha-ketocarboxylic acids as inhibitors of protein tyrosine phosphatases. J Med Chem 45:3946–3952

    Article  PubMed  CAS  Google Scholar 

  • Chen H, Cong LN, Li Y, Yao ZJ, Wu L, Zhang ZY, Burke TR Jr., Quon MJ (1999) A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. Biochemistry 38:384–389

    Article  PubMed  CAS  Google Scholar 

  • Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, Stallings WC, Connolly DT, Shoichet BK (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem 45:2213–2221

    Article  PubMed  CAS  Google Scholar 

  • Elchebly M, Payette P, Michaliszyn E, Cromlish W, Colins S, Loy AL, Normandin D, Chenng A, Himms-Hagen JC, Chan C (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548

    Article  PubMed  CAS  Google Scholar 

  • Evans JL, Jallal B (1999) Protein tyrosine phosphatases: their role in insulin action and potential as drug targets. Exp Opin Invest Drugs 8:139–160

    Article  CAS  Google Scholar 

  • Fu H, Park J, Pei D (2002) Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases. Biochemistry 41:10700–10709

    Article  PubMed  CAS  Google Scholar 

  • Goodman LS, Gilman AG (2001) The pharmacological basis of therapeutics, 10th edn. McGraw Hill Publications, New York, pp 1679–1710

    Google Scholar 

  • Hooft van Huijsduijnen R, Sauer WH, Bombrun A, Swinnen D (2004) Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J Med Chem 47:4142–4146

    Article  PubMed  CAS  Google Scholar 

  • Hussain M, Ahmed V, Hill B, Ahmed Z, Taylor SD (2008) A re-examination of the difluoromethylene sulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition. Bioorg Med Chem 16:6764–6777

    Article  PubMed  CAS  Google Scholar 

  • Joshi P, Tanwar OP, Rambhade S, Bhaisare M, Jain D (2012a) 2-D QSAR studies of steroidal natural products oleanic acid and their semisynthetic derivatives as potent protein tyrosine phosphatase 1B inhibitors. Med Chem Res 21:351–356

    Article  CAS  Google Scholar 

  • Joshi P, Deora GS, Tanwar OP, Rathor V, Rawat AK, Srivastava AK, Jain D (2012) Identification of ZINC02765569: a potent inhibitor of PTP1B by vHTS. Med Chem Res. doi:10.1007/s00044-012-0007-0

  • Kenner KA, Anyanwu E, Olefsky JM, Kusari J (1996) Protein- tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271:19810–19816

    Article  PubMed  CAS  Google Scholar 

  • Klaman LD, Boss O, Peroni OD, Kim JK, Zabotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–5489

    Article  PubMed  CAS  Google Scholar 

  • Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA (1992) Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130:2535–2544

    Article  PubMed  CAS  Google Scholar 

  • Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240–1247

    Article  PubMed  CAS  Google Scholar 

  • Liljebris C, Larsen SD, Ogg D, Palazuk BJ, Bleasdale JE (2002a) Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity. J Med Chem 45:1785–1798

    Article  PubMed  CAS  Google Scholar 

  • Liljebris C, Martinsson J, Tedenborg L, Williams M, Barker E, Duffy JES, Nygren A, James S (2002b) Synthesis and biological activity of a novel class of pyridazine analogues as non- competitive reversible inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem 10:3197–3212

    Article  PubMed  CAS  Google Scholar 

  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26

    Article  PubMed  CAS  Google Scholar 

  • Lund IK, Andersen HS, Iversen LF, Olsen OH, Moller KB, Pedersen AK, Ge Y, Holsworth DD, Newman MJ, Axe FU, Moller NP (2004) Structure-based design of selective and potent inhibitors of protein–tyrosine phosphatase beta. J Biol Chem 279:24226–24235

    Article  PubMed  CAS  Google Scholar 

  • Maccari R, Paoli P, Ottana R, Jacomelli M, Ciurleo R, Manao G, Steindl T, Langer T, Vigoritaa MG, Camici G (2007) 5-Arylidine-2,4-thiazolidinedione as inhibitors of PTP 1B. Bioorg Med Chem Lett 15:5137–5149

    Article  CAS  Google Scholar 

  • Maestro, version 9.2 (2011) Schro¨dinger. LLC, New York

  • Malamas MS, Sredy J, Gunawan I, Mihan B, Sawicki DR, Seestaller L, Sullivan D, Flam BR (2000) New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties. J Med Chem 43:995–1010

    Article  PubMed  CAS  Google Scholar 

  • Martin B, Pallen CJ, Wang JH, Graves DJ (1985) Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem 260:14932–14937

    PubMed  CAS  Google Scholar 

  • Ramachandran C, Aebersold R, Tonks NK, Pot DA (1992) Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases. Biochemistry 31:4232–4238

    Article  PubMed  CAS  Google Scholar 

  • Rotella DP (2004) Novel ‘‘second-generation’’ approaches for the control of type 2 diabetes. J Med Chem 47:4111–4112

    Article  PubMed  CAS  Google Scholar 

  • Seely BL, Staubs PA, Reichar DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379–1385

    Article  PubMed  CAS  Google Scholar 

  • Seiner DR, LaButti JN, Gates KS (2007) Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein. Chem Res Toxicol 20:1315–1320

    Article  PubMed  CAS  Google Scholar 

  • Sell SM, Reese D (1999) Insulin-inducible changes in the relative ratio of PTP1B splice variants. Mol Genet Metab 66:189–192

    Article  PubMed  CAS  Google Scholar 

  • Sparks RB, Polam P, Zhu W, Crawley ML, Takvorian A, McLaughlin E, Wei M, Ala PJ, Gonneville L, Taylor N, Li Y, Wynn R, Burn TC, Liu PC, Combs AP (2007) Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors. Bioorg Med Chem Lett 17(3):736–740

    Article  PubMed  CAS  Google Scholar 

  • Wang XY, Bergdahl K, Heijbel A, Liljebris C, Bleasdale JE (2001) Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors. Mol Cell Endocrinol 173:109–119

    Article  PubMed  CAS  Google Scholar 

  • Wrobel J, Li Z, Sredy J, Sawicki DR, Seestaller L, Sullivan D (2000) Synthesis and PTP1B inhibition of novel 4-aryl-1-oxa-9-thiacyclopenta[b]fluorenes. Bioorg Med Chem Lett 10:1535–1538

    Article  PubMed  CAS  Google Scholar 

  • Xin Z, Oost TK, Abad-Zapatero C, Hajduk PJ, Pei Z, Szczepankiewicz BG, Hutchins CW, Ballaron SJ, Stashko MA, Lubben T (2003) Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13:1887–1890

    Article  PubMed  CAS  Google Scholar 

  • Zhang ZY (2001) Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 5:416–423

    Article  PubMed  CAS  Google Scholar 

  • Zhang ZY (2003) Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Acc Chem Res 36:385–392

    Article  PubMed  CAS  Google Scholar 

  • Zhang ZY, Lee SY (2003) PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs 12:223–233

    Article  PubMed  CAS  Google Scholar 

  • Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhanot S, Monia BP, Jirousek MR (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99:11357–11362

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal, 460 023, India

    Prashant Joshi, Girdhar Singh Deora & Deepti Jain

  2. Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, 500 046, India

    Girdhar Singh Deora

  3. B. N. Girls College of Pharmacy, Udaipur, 313 002, India

    Vandana Rathore

  4. Division of Biochemistry, Central Drug Research Institute, Lucknow, 226 001, India

    Arun K. Rawat & A. K. Srivastava

Authors
  1. Prashant Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Girdhar Singh Deora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vandana Rathore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arun K. Rawat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. K. Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deepti Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Prashant Joshi or Girdhar Singh Deora.

Additional information

Prashant Joshi, Girdhar Singh Deora contributed equally to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joshi, P., Deora, G.S., Rathore, V. et al. Molecular modeling and synthesis of ZINC02765569 derivatives as protein tyrosine phosphatase 1B inhibitors: lead optimization study. Med Chem Res 22, 1618–1623 (2013). https://doi.org/10.1007/s00044-012-0165-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-012-0165-0

Keywords

Search

Navigation